Bortezomib

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

Company

DUNS: 141588017

Effective Date

July 25, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Bortezomib(3.5 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC Product Code

0409-1700

Application Number

ANDA208460

Marketing Category

ANDA (C73584)

Route of Administration

INTRAVENOUS, SUBCUTANEOUS

Effective Date

July 25, 2022

Ingredients

MANNITOLInactive

Code: 3OWL53L36AClass: IACTQuantity: 35 mg in 1 1

Code: 69G8BD63PPClass: ACTIBQuantity: 3.5 mg in 1 1